메뉴 건너뛰기




Volumn 108, Issue 3, 2016, Pages

Prospective Clinical Study of Precision Oncology in Solid Tumors

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; COLORECTAL CANCER; FEMALE; GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLID TUMOR; BILIARY TRACT NEOPLASMS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA SEQUENCE; FEASIBILITY STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; NEOPLASMS; ONCOLOGY; PANCREATIC NEOPLASMS; PERSONALIZED MEDICINE; TRENDS;

EID: 84958985365     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv332     Document Type: Article
Times cited : (76)

References (15)
  • 2
    • 70849116358 scopus 로고    scopus 로고
    • Profiling critical cancer gene mutations in clinical tumor samples
    • MacConaill LE, Campbell CD, Kehoe SM, et al. Profiling critical cancer gene mutations in clinical tumor samples. PloS One. 2009;4(11):e7887.
    • (2009) PloS One. , vol.4 , Issue.11 , pp. e7887
    • MacConaill, L.E.1    Campbell, C.D.2    Kehoe, S.M.3
  • 3
    • 84880473776 scopus 로고    scopus 로고
    • Personalizing oncology: Perspectives and prospects
    • Mendelsohn J. Personalizing oncology: perspectives and prospects. J Clin Oncol. 2013;31(15):1904-1911.
    • (2013) J Clin Oncol. , vol.31 , Issue.15 , pp. 1904-1911
    • Mendelsohn, J.1
  • 4
    • 84903522671 scopus 로고    scopus 로고
    • Implementing personalized cancer care
    • Schilsky RL. Implementing personalized cancer care. Nat Rev Clin Oncol. 2014;11(7):432-438.
    • (2014) Nat Rev Clin Oncol. , vol.11 , Issue.7 , pp. 432-438
    • Schilsky, R.L.1
  • 5
    • 84941962196 scopus 로고    scopus 로고
    • Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
    • Chantrill LA, Nagrial AM, Watson C, et al. Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial. Clin Cancer Res. 2015;21(9):2029-2037.
    • (2015) Clin Cancer Res. , vol.21 , Issue.9 , pp. 2029-2037
    • Chantrill, L.A.1    Nagrial, A.M.2    Watson, C.3
  • 6
    • 84901936604 scopus 로고    scopus 로고
    • Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel
    • Johnson DB, Dahlman KH, Knol J, et al. Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel. Oncologist. 2014;19(6):616-622.
    • (2014) Oncologist. , vol.19 , Issue.6 , pp. 616-622
    • Johnson, D.B.1    Dahlman, K.H.2    Knol, J.3
  • 7
    • 84901918076 scopus 로고    scopus 로고
    • Molecular tumor board: The university of California san diego moores cancer center experience
    • Schwaederle M, Parker BA, Schwab RB, et al. Molecular Tumor Board: The University of California San Diego Moores Cancer Center Experience. Oncologist. 2014;19(6):631-636.
    • (2014) Oncologist. , vol.19 , Issue.6 , pp. 631-636
    • Schwaederle, M.1    Parker, B.A.2    Schwab, R.B.3
  • 8
    • 84900829967 scopus 로고    scopus 로고
    • Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
    • Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998-2006.
    • (2014) JAMA. , vol.311 , Issue.19 , pp. 1998-2006
    • Kris, M.G.1    Johnson, B.E.2    Berry, L.D.3
  • 9
    • 84941361474 scopus 로고    scopus 로고
    • Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment onto Genomically Matched Clinical Trials
    • Meric-Bernstam F, Brusco L, Shaw K, et al. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. J Clin Oncol. 2015;33(25):2753-2762.
    • (2015) J Clin Oncol. , vol.33 , Issue.25 , pp. 2753-2762
    • Meric-Bernstam, F.1    Brusco, L.2    Shaw, K.3
  • 10
    • 57849117384 scopus 로고    scopus 로고
    • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
    • Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.
    • (2009) Eur J Cancer. , vol.45 , Issue.2 , pp. 228-247
    • Eisenhauer, E.A.1    Therasse, P.2    Bogaerts, J.3
  • 11
    • 84887491073 scopus 로고    scopus 로고
    • Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
    • Frampton GM, Fichtenholtz A, Otto GA, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023-1031.
    • (2013) Nat Biotechnol. , vol.31 , Issue.11 , pp. 1023-1031
    • Frampton, G.M.1    Fichtenholtz, A.2    Otto, G.A.3
  • 12
    • 84896730857 scopus 로고    scopus 로고
    • Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: A multicentre, prospective trial (SAFIR01/UNICANCER)
    • Andre F, Bachelot T, Commo F, et al. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol. 2014;15(3):267-274.
    • (2014) Lancet Oncol. , vol.15 , Issue.3 , pp. 267-274
    • Andre, F.1    Bachelot, T.2    Commo, F.3
  • 13
    • 84904108521 scopus 로고    scopus 로고
    • Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: Results of the feasibility part of the SHIVA trial
    • Le Tourneau C, Paoletti X, Servant N, et al. Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial. Br J Cancer. 2014;111(1):17-24.
    • (2014) Br J Cancer. , vol.111 , Issue.1 , pp. 17-24
    • Le Tourneau, C.1    Paoletti, X.2    Servant, N.3
  • 14
    • 84938209813 scopus 로고    scopus 로고
    • A decision support framework for genomically informed investigational cancer therapy
    • Meric-Bernstam F, Johnson A, Holla V, et al. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst. 2015;107(7):djv098 doi:10.1093/jnci/djv098.
    • (2015) J Natl Cancer Inst. , vol.107 , Issue.7 , pp. djv098
    • Meric-Bernstam, F.1    Johnson, A.2    Holla, V.3
  • 15
    • 84902674966 scopus 로고    scopus 로고
    • Correlation of somatic mutations and clinical outcome in melanoma patients treated with carboplatin, paclitaxel, and sorafenib
    • Wilson MA, Zhao F, Letrero R, et al. Correlation of somatic mutations and clinical outcome in melanoma patients treated with carboplatin, paclitaxel, and sorafenib. Clin Cancer Res. 2014;20(12):3328-3337.
    • (2014) Clin Cancer Res. , vol.20 , Issue.12 , pp. 3328-3337
    • Wilson, M.A.1    Zhao, F.2    Letrero, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.